Effect of Levetiracetam on Benzodiazepine Withdrawal Syndrome
Phase 3
Recruiting
- Conditions
- Benzodiazepine Withdrawal Syndrome.Adverse effect of benzodiazepinesT42.4X5
- Registration Number
- IRCT20200701047979N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
Patients who had been taking Benzodiazepines for at least three months, and have not discontinued them for more than one month.
Exclusion Criteria
Patients diagnosed with acute and major psychological disorders, schizophrenia, epilepsy, or concurrent neurological disorders, e.g. Multiple Sclerosis
Patients with a history of taking Levetiracetam or receiving concurrent Gabapentin or Carbamazepine in the last six months
Patients younger than 15 years of age
Allergic reactions to Levetiracetam or its excipients
Severe adverse drug reactions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sum of Scores for CIWA-B Questionnaire. Timepoint: At benzodiazepine cessation and before taking Levetiracetam, then 2 weeks after taking Levetiracetam. Method of measurement: CIWA-B Questionnaire.
- Secondary Outcome Measures
Name Time Method